SESSION 11 SCHEDULE
Thursday
SESSION 11: NEW DEVELOPMENTS IN TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) AND ENDOVASCULAR TREATMENT OF OTHER CARDIAC AND ASCENDING AORTIC AND ARCH LESIONS (5-MINUTE TALKS)
x
PROGRAM A (SESSIONS 11-13) LOCATION: GRAND BALLROOM, 3RD FLOOR
6:30 AM - 6:35 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
6:35 AM - 6:40 AM Embolic Protection With The EMBRELLA Device To Cover The Origin Of The Innominate And Left Common Carotid During TAVI And TEVAR
  Presenter(s):Jeffrey P. Carpenter, MD  
6:41 AM - 6:51 AM Status Of TAVI: A Cardiologistís View And Insights From The PARTNER A&B Trials
  Presenter(s):Martin B. Leon, MD  
6:52 AM - 6:57 AM Status Of Transcatheter Mitral Valve Repair: 2-Year Experience With The MitraClip For Mitral Insufficiency: The EVEREST II Trial
  Presenter(s):Ted Feldman, MD  
6:58 AM - 7:03 AM There Will Always Be A Need For Open Repair Of Ascending Aorta And Arch Lesions
  Presenter(s):Joseph S. Coselli, MD  
7:04 AM - 7:09 AM Transcardiac And Other Access Routes To The Ascending Aorta: Tips For Dealing With Difficult Access From Below
  Presenter(s):Tilo Koelbel, MD, PhD  
7:10 AM - 7:15 AM What Percentage Of Type A Aortic Dissections Could Be Treated Endovascularly
  Presenter(s):Stephan Haulon, MD  
7:16 AM - 7:21 AM Early Clinical Experience With Endovascular Treatment Of Type A Aortic Dissections By A Specially Designed Industry-Made Endograft
  Presenter(s):Matt M. Thompson, MD  
7:22 AM - 7:27 AM New Concepts In The Endovascular Treatment Of Type A Aortic Dissection
  Presenter(s):Nicola Mangialardi, MD  
7:28 AM - 7:33 AM Stent-Grafts In The Ascending Aorta: Doís And Doníts In View Of Open Repair Results And Findings
  Presenter(s):Burkhart Zipfel, MD  
7:34 AM - 7:41 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Thursday
SESSION 12: NEW DEVELOPMENTS IN MANAGEMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS (5-MINUTE TALKS)
x
PROGRAM A (SESSIONS 11-13) LOCATION: GRAND BALLROOM, 3RD FLOOR
7:41 AM - 7:46 AM New Device For Branched Graft Reconstructions For Arch Aneurysms
  Presenter(s):Krassi Ivancev, MD, PhD  
7:47 AM - 7:52 AM Endovascular Treatment Of Aortic Arch Aneurysms: Early Clinical Experience With A Branched Arch Stent-Graft
  Presenter(s):Roy K. Greenberg, MD  
7:53 AM - 7:58 AM The Only Way To Chronic Treat Type B Aortic Dissections Is By Sealing The Primary Entry Tear And All Other Re-Entry Sites By Endovascular Methods
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
7:59 AM - 8:04 AM Closing The Primary Entry Tear With An Endograft Is Only The First Step In Treating Chronic Type B Aortic Dissections Effectively
  Presenter(s):Pedro Puech, MD  
8:05 AM - 8:10 AM DEBATE: Chimney And Sandwich Techniques Are A Good Solution For Treating Arch Aneurysms
  Presenter(s):Armando C. Lobato, MD, PhD  
8:11 AM - 8:16 AM DEBATE: Respiratory And circulatory Motion Effects Make The Arch Unsuitable For Chimney And Sandwich Grafts For Revascularizing Arch Branches
  Presenter(s):Frank R. Arko, MD  
8:17 AM - 8:22 AM What Is The Incidence And Significance Of Aortic Remodeling, Complete And Partial After TEVAR For Acute Type B Aortic Dissection: Is Partial False Lumen Thrombosis Good Or Bad
  Presenter(s):Mark Conrad, MD  
8:23 AM - 8:28 AM Optimal Treatment For Chronic Type B Aortic Dissection: Do Newer Thoracic Endograft Systems Help
  Presenter(s):Giovanni Torsello, MD  
8:29 AM - 8:34 AM Early Experience And Use Of Single Branched Aortic Endograft To Treat Aortic Dissections
  Presenter(s):Zhong Gao Wang, MD  
8:35 AM - 8:40 AM Lessons Learned In 18 Years Of Treating Type B Aortic Dissections In Japan
  Presenter(s):Toru Kuratani, MD, PhD  
8:41 AM - 8:47 AM Panel Discussion
END OF SESSION 12
 
SESSION 13 SCHEDULE
Thursday
SESSION 13: PROGRESS IN UNDERSTANDING AND MANAGEMENT OF AORTIC DISSECTIONS (5-MINUTE TALKS)
Moderators:Weiguo Fu, MD / Michael D. Dake, MD  
x
PROGRAM A (SESSIONS 11-13) LOCATION: GRAND BALLROOM, 3RD FLOOR
8:48 AM - 8:53 AM Techniques For Open Surgical Options For Complicated Type B Aortic Dissections Have Stood The Test Of Time: What Percentage Of Patients Will Require Open Surgery In The Future
  Presenter(s):Hazim J. Safi, MD  
8:54 AM - 8:59 AM A Novel Branch Stent Graft To Treat Aortic Arch Aneurysms And Dissections: Early And Mid-Term Results
  Presenter(s):Zaiping Jing, MD  
9:00 AM - 9:05 AM Endovascular Treatment Of Complicated Type B Aortic Dissections: Factors Determining How Much Aortic Coverage We Need And With What Sort Of Stent-Graft (Open Or Covered)
  Presenter(s):Matt M. Thompson, MD  
9:06 AM - 9:11 AM Quantitative Differences In False Lumen Evolution With And Without A Petticoat (Open Stent) Below A Standard Covered Stent For Type B Aortic Dissections
  Presenter(s):Germano Melissano, MD  
9:12 AM - 9:17 AM Disease-Specific Devices For Treating Type B Aortic Dissections: What Are The Results Of The STABLE Trial With A Proximal Covered And A Distal Bare Stent Showing Us
  Presenter(s):Joseph V. Lombardi, MD / Christoph A. Nienaber, MD, PhD  
9:18 AM - 9:23 AM What Is The Need For Open Repair Of Thoracic Aneurysms In The Endovascular Era: As Primary Procedures And After TEVAR Failures
  Presenter(s):Michael J. Jacobs, MD  
9:24 AM - 9:29 AM TEVAR For Acute Type B Dissections Is Not A Single Step Procedure: Permanent Surveillance And Reinterventions May Be Required
  Presenter(s):GŲtz M. Richter, MD, PhD  
9:30 AM - 9:35 AM The Natural History Of Type B Aortic Dissection: Which Patients Should We Treat: What We Know And What We Donít Know
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
9:36 AM - 9:41 AM Hybrid Procedures Still Have A Major Role For Complex And Difficult Aneurysms Of The Aortic Arch And Thoracic Aorta
  Presenter(s):Roberto Chiesa, MD  
9:42 AM - 9:47 AM What Are The Latest Results With TEVAR For Aneurysms Involving The Aortic Arch, Zones 0-3: Are The New Devices Helping
  Presenter(s):Dittmar Boeckler, MD  
9:48 AM - 9:55 AM Panel Discussion
9:55 AM - 10:10 AM Break - Visit Exhibits and Pavilions (2nd and 3rd Floors)
END OF SESSION 13
 
SESSION 14 SCHEDULE
Thursday
SESSION 14: LOWER EXTREMITY HOT TOPICS 1 (5-MINUTE TALKS)
x
PROGRAM B (SESSIONS 14-16) LOCATION: TRIANON BALLROOM, 3RD FLOOR
6:35 AM - 6:40 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
6:40 AM - 6:45 AM Optimizing POBA With Focal Force Balloons: What Are They And Do They Work With Heavily Calcified Arteries
  Presenter(s):Craig M. Walker, MD  
6:46 AM - 6:51 AM Tips And Tricks For Antegrade Puncture Of The CFA: How To Get The Wire Easily Into The SFA
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
6:52 AM - 6:57 AM When And How To Use Embolic Protection Devices In The Lower Extremity
  Presenter(s):Peter A. Schneider, MD  
6:58 AM - 7:03 AM PTA (POBA) vs. Stenting For SFA/Popliteal Disease: Are Late Outcomes Equivalent
  Presenter(s):Kenneth Rosenfield, MD  
7:04 AM - 7:09 AM Endovascular vs. Open Surgical Treatments: A Common Sense Approach To The TASC System
  Presenter(s):Jos C. van den Berg, MD, PhD  
7:10 AM - 7:15 AM Role Of Bare Metal Stents For Below Knee Lesions Causing CLI: When Do They Help And When Not: Results Of The Belgian BTK Trial: What Is The Need For Reintervention At 1 Year
  Presenter(s):Frank E.G. Vermassen, MD, PhD  
7:16 AM - 7:21 AM Advantages And Limitations Of Drug Eluting Balloons (DEBs): Do They Improve On The Results Of PTA With Uncoated Balloons For The Treatment Of Primary Lesions And After Atherectomy
  Presenter(s):Gunnar Tepe, MD  
7:22 AM - 7:27 AM What Is The Effectiveness Of The Angioslide Embolic Debris Capture Device And When Should It Be Used
  Presenter(s):Thomas Zeller, MD  
7:28 AM - 7:33 AM Supera Veritas Stent: Why Is It A Better Solution For Extensive Femoropopliteal Disease
  Presenter(s):Peter C.J. Goverde, MD  
7:34 AM - 7:40 AM Panel Discussion
END OF SESSION 14
 
SESSION 15 SCHEDULE
Thursday
SESSION 15: LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
x
7:40 AM - 7:45 AM Tips And Tricks For Endovascular Treatment Of Chronically Occluded Prosthetic Bypasses Associated With CLI
  Presenter(s):Craig M. Walker, MD  
7:46 AM - 7:51 AM Endovascular Stenting Of CFA Lesions Is Possible And Can Be Associated With Good Midterm Outcomes
  Presenter(s):Nicolas A. Diehm, MD / Iris Baumgartner, MD  
7:52 AM - 7:57 AM DEBATE: Balloon PTA Is Usually Best In The Tibials: There Is Really A Need For Other Devices
  Presenter(s):Peter A. Schneider, MD  
7:58 AM - 8:03 AM DEBATE: Drug Eluting Stents (DESs) Used In Below Knee Arteries Improve Limb Salvage Outcomes Over POBA: Summary Of The Evidence
  Presenter(s):Thomas Zeller, MD  
8:04 AM - 8:09 AM Effectiveness Of Paclitaxil Coated DEBs For Treating In Stent Restenosis (The PACUBA Trial)
  Presenter(s):Johannes Lammer, MD  
8:10 AM - 8:15 AM 2-Year Results Of The Zilver PTX Trial: The Benefits Are Worthwhile
  Presenter(s):Michael D. Dake, MD  
8:16 AM - 8:21 AM Can Popliteal Stents Work: Tips, Tricks And Precautions
  Presenter(s):Gary M. Ansel, MD  
8:22 AM - 8:27 AM Top Ten Tips And New Technology For Performing Endovascular Treatments To The Foot: What Percentage Of Patients With CLI Will Need Open Surgery At Some Point In Their Ccourse: An Enthusiastic Inerventionalist's Perspective
  Presenter(s):Marco G. Manzi, MD  
8:28 AM - 8:33 AM Another View And Update On The Role Of DESs And DEBSs In Treating Below-Knee Disease: How Durable Are These Treatments
  Presenter(s):Andrej Schmidt, MD, PhD  
8:34 AM - 8:39 AM 2-Year Results With A Device To Remove The Atherosclerotic Core Of Long SFA Occlusions And Line It With A Distally Sented PTFE Graft Inserted Through The Groin
  Presenter(s):Patrice F. Bergeron, MD / Dieter Raithel, MD, PhD / Patrick Peeters, MD  
8:40 AM - 8:46 AM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Thursday
SESSION 16: LOWER EXTREMITY HOT TOPICS III (5-MINUTE TALKS)
x
8:46 AM - 8:51 AM DEBATE: In Lower Extremity PTAs Intraluminal Is Better Than Subintimal
  Presenter(s):Marc Bosiers, MD  
8:52 AM - 8:57 AM DEBATE: Nonsentse, In Lower Extremity PTAs, Subintimal Is Better
  Presenter(s):George H. Meier III, MD  
8:58 AM - 9:03 AM Should PTAs Of The SFA Alwys Be Stented: Based On Prospective Follow-up Of 850 Patients
  Presenter(s):Robert Y. Rhee, MD  
9:04 AM - 9:09 AM Another View On Embolization During Lower Extremity Interventions: When Is Embolic Protection Needed And How Should It Be Done
  Presenter(s):Nicholas J. Morrissey, MD  
9:10 AM - 9:15 AM Tips And Tricks For Reentry Into The Lumen From The Subintimal Space
  Presenter(s):Peter A. Schneider, MD  
9:16 AM - 9:21 AM Another Single Center Experience Wth The Value Of DEBs For Femoropopliteal Lesions
  Presenter(s):Plinio Rossi, MD  
9:22 AM - 9:27 AM Does Debulking Before Using DEBs Help Wtih Primary Atherosclerotic Lesions; With In-Stent Restenosis: Ho Should It Be Done?
  Presenter(s):Andrej Schmidt, MD, PhD / Dierk Scheinert, MD  
9:28 AM - 9:33 AM Some Negative Aspects Of Tibial Angioplasty Based On U.S. Medicare Data In Patients With CLI: Complications Reshospitalizations And Amputations Are Frequent After The Procedures
  Presenter(s):Alan M. Graham, MD / Todd R. Vogel, MD  
9:34 AM - 9:39 AM Value Of Atherectomy Devices And Lasers For Lower Extremity Occlusive Lesions: Which Ones Make A Difference And When Should They Be Used
  Presenter(s):Thomas Zeller, MD  
9:40 AM - 9:45 AM Long-Term Results Of Ultrasound Enhanced Thrombolysis For Acute Arterial Occlusions: Results Of The Dutch Multicenter Study
  Presenter(s):Jean-Paul de Vries, MD, PhD  
9:46 AM - 9:51 AM Panel Discussion
9:46 AM - 9:51 AM Panel Discussion
9:51 AM - 10:10 AM Break - Visit Exhibit and Pavilions (2nd and 3rd Floors)
END OF SESSION 16
 
SESSION 17 SCHEDULE
Thursday
SESSION 17: NEW DEVELOPMENTS IN LOWER EXTREMITY SFA AND CRURAL ARTERY TREATMENT AND CLI TREATMENT (5-MINUTE TALKS)
x
PLENARY SESSION - LOCATION: GRAND BALLROOM, 3RD FLOOR
10:10 AM - 10:15 AM Flaws And Limitations In The TASC II Classification System: We Now Need Something Better: Will We Ever Get It
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
10:16 AM - 10:21 AM What Are The Most Exciting New Developments In The Treatment Of Lower Extremity Ischemia: Will More Or Fewer LE Bypasses Be Required Than In The 25-30% Of CLI Patients Estimated Last Year
  Presenter(s):Joseph L. Mills, MD  
10:22 AM - 10:27 AM DEBATE: Endovascular First Is Not Appropriate For All CLI Patients: Evidence For A Selective Approach To Revascularization
  Presenter(s):Michael S. Conte, MD  
10:28 AM - 10:33 AM DEBATE: Endovascular First Is Best In All CLI Patients
  Presenter(s):Iris Baumgartner, MD  
10:34 AM - 10:39 AM Latest Information On Autologous Bone Marrow Cell: Administration For CLI: Does It Work: Is There Proof: Which Patients Should Have It
  Presenter(s):John (Jeb) W. Hallett, MD  
10:40 AM - 10:45 AM 12 Commandments For BTK Interventions For CLI
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
10:46 AM - 10:51 AM Perfusion Imaging Is Mandatory To Demonstrate Efficacy Of PTA And Other Tibial Artery Interventions: Angiography Alone Can Be Misleading
  Presenter(s):Werner Lang, MD  
10:52 AM - 10:57 AM Results Of DESTINY RCT Comparing DESs (XCIENCE V) vs. Bare Metal Stents (BMS) In Below-Knee Lesions: DESs Give Better Patency Despite Increased Cost
  Presenter(s):Giovanni Torsello, MD / Marc Bosiers, MD  
10:58 AM - 11:06 AM Panel Discussion
Moderator(s): Mark A. Adelman, MD / Plinio Rossi, MD  
11:06 AM - 11:11 AM Advances In Distal Puncture And Retrograde Crossing Of Occlusive Lesions: Puncture Of Tibial And Peroneal Arteries In Proximal Two-Thirds Of Leg And Use Of Collateral Branches
  Presenter(s):Andrej Schmidt, MD, PhD  
11:12 AM - 11:17 AM DEBATE: Current Status Of Bare Metal And Drug Eluting Stents In SFA, Popliteal And Crural Artery Lesions: DESs Are Best
  Presenter(s):Johannes Lammer, MD  
11:18 AM - 11:23 AM DEBATE: DESs In The SFA Is More Of The Same And A Waste Of Money
  Presenter(s):Patrick Peeters, MD  
11:24 AM - 11:29 AM Should Stents Be Used Routinely After SFA Subintimal Angioplasty
  Presenter(s):George H. Meier III, MD  
11:30 AM - 11:35 AM 1 Ĺ-Year Results Of Drug Eluting Balloons In The Treatment Of SFA Lesions: The Italian Multicenter Trial
  Presenter(s):Giancarlo Biamino, MD, PhD  
11:36 AM - 11:41 AM Clinical And Cost Effectiveness Of Below-Knee DESs
  Presenter(s):Konstantinos Katsanos, MD, MSc, PhD, EBIR  
11:42 AM - 11:47 AM What To Watch Out For With DESs And DEBs: There May Be Real Disadvantages (Web-Based)
  Presenter(s):Renu Virmani, MD  
11:48 AM - 11:53 AM Below The Elbow PTA In Critical Hand Ischemia In Dialysis And Other Patients: A New Horizon
  Presenter(s):Roberto Ferraresi, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 12:54 PM Lunch Break Ė Americas Hall I, 3rd Floor
Visit Exhibits and Pavilions (2nd and 3rd Floors)

END OF SESSION 17
 
SESSION 18 SCHEDULE
Thursday
SESSION 18: LUNCHEON PROGRAM: MANAGEMENT OF PROXIMAL VENOUS OBSTRUCTION. (PRE-REGISTRATION IS REQUIRED. PLEASE E-MAIL ADMIN@VEITHSYMPOSIUM.ORG TO PRE-REGISTER COMPLIMENTARY.)
x
SPECIAL LUNCHEON SESSION - LOCATION: CONFERENCE ROOM A, CONCOURSE LEVEL
12:00 PM - 12:05 PM Opening Remarks
  Presenter(s):Kenneth Ouriel, MD, MBA, FACS, FACC  
12:05 PM - 12:15 PM Is There A Role For Thrombolysis And/Or Mechanical Thrombectomy In Acute Proximal Deep Venous Thrombosis
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
12:15 PM - 12:25 PM The Use Of Venous Stenting For Subacute And Chronic Proximal Venous Obstruction
  Presenter(s):Ziv J. Haskal, MD, FACR, FAHA, FSIR  
12:25 PM - 12:35 PM Open Surgical Procedures Are Best For Obstruction Of The Iliofemoral Veins And Inferior Vena Cava
  Presenter(s):Peter Gloviczki, MD  
12:35 PM - 12:55 PM Discussion And Closing Remarks
12:50 PM - 12:54 PM Adjourn - Transition to Plenary Sessions. VEITHsymposium continues in the Grand Ballroom, 3rd Floor; AIMsymposium continues in the Trianon Ballroom, 3rd Floor.
END OF SESSION 18
 
SESSION 19 SCHEDULE
Thursday
SESSION 19: NEW DEVELOPMENTS IN TEVAR AND EVAR (5-MINUTE TALKS)
x
12:54 PM - 12:59 PM How To Use 3D Imaging To Decrease Complications Of TAVI With The Edwards Sapien Balloon Expandable Aortic Valve
  Presenter(s):Erno Remsey-Semmelweis, MD, PhD  
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR
1:00 PM - 1:05 PM DEBATE: New Evidence That Early TEVAR For Uncomplicated Acute Type B Aortic Dissection Is Superior To Medical Treatment And Delayed Selective TEVAR
  Presenter(s):Rodney A. White, MD  
1:06 PM - 1:11 PM DEBATE: TEVAR For Acute Type B Dissection May Not Be The Best Option In Most Patients
  Presenter(s):Jean-Pierre Becquemin, MD, FRCS  
1:12 PM - 1:17 PM How To Decrease Spinal Cord Ischemia (SCI) And Stroke After TEVAR: How To Perform CSF Drainage Optimally
  Presenter(s):Vincent Riambau, MD, PhD  
1:18 PM - 1:23 PM DEBATE: With Coverage Of Left Subclavian Orifice During TEVAR, Revascularization Is Mandatory: The SVS Guidelines Say So
  Presenter(s):Mark A. Farber, MD  
1:24 PM - 1:29 PM DEBATE: With Coverage Of Left Subclavian Orifice During TEVAR, Revascularization Is Not Mandatory And May Be harmful Based On New Multicenter Data
  Presenter(s):Thomas S. Maldonado, MD  
1:30 PM - 1:35 PM Sutureless Clampless Telescoping Method For Aortic And Arterial Anastomoses Using An Endograft Connector (Video)
  Presenter(s):Mario Lachat, MD  
1:36 PM - 1:41 PM DEBATE: Open Repair Should Be The Treatment Of Choice For Elective AAAs
  Presenter(s):Wilhelm Sandmann, MD  
1:42 PM - 1:47 PM DEBATE: EVAR Should Be The Treatment Of Choice For AAA In All Anatomically Suitable Patients Requiring Repair
  Presenter(s):Christopher K. Zarins, MD  
1:48 PM - 1:53 PM EVAR Is Better Than Open Repair Long-Term Despite EVAR I And Other Trials
  Presenter(s):Juan C. Parodi, MD  
1:54 PM - 1:59 PM Population Based Studies Show That EVAR Is Better Than Open Repair
  Presenter(s):Marc L. Schermerhorn, MD  
2:00 PM - 2:05 PM Twin Track Approach To Avoid Late AAA Sac Rupture After EVAR
  Presenter(s):Roger M. Greenhalgh, MD  
2:06 PM - 2:11 PM Panel Discussion
END OF SESSION 19
 
SESSION 20 SCHEDULE
Thursday
SESSION 20: CRITICAL EVALUATION OF CAROTID ARTERY STENTING (CAS) IN NOVEMBER 2011: WHERE IS IT AND WHERE IS IT GOING (5-MINUTE TALKS)
x
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR
2:11 PM - 2:16 PM Tips And Tricks For Performing CAS Under Difficult Circumstances: Limitations Of Current Platforms And How Will They Be Improved
  Presenter(s):Bernhard Reimers, MD  
2:17 PM - 2:22 PM Tips And Tricks To Make CAS Safer: Why Do Most Strokes Occur After Embolic Protection Devices Are Out: How Can CAS Stroke Rates Best Be Decreased
  Presenter(s):Emmanuel M. Houdart, MD  
2:23 PM - 2:28 PM Beyond Technique And Embolic Protection How Can We Prevent Strokes With CAS: Where Do We Stand With Mesh Or Membrane Covered Stents
  Presenter(s):Sumaira Macdonald, MBChB (Comm), FRCP, FRCR, PhD  
2:29 PM - 2:34 PM Safety Of CAS WITHOUT Embolic Protection Devices: Why Do We Ignore The Evidence
  Presenter(s):Jos C. van den Berg, MD, PhD  
2:35 PM - 2:40 PM DEBATE: CAS Is The Treatment Of Choice For Most Symptomatic And Asymptomatic High-Grade Stenosis: A CAS Enthusiast Interprets CREST
  Presenter(s):William A. Gray, MD  
2:41 PM - 2:46 PM DEBATE: CEA Is Best For Most Symptomatic And Some Asymptomatic Carotid Stenosis Patients: A CEA Enthusiast Interprets CREST
  Presenter(s):Wesley S. Moore, MD  
2:47 PM - 2:52 PM DEBATE: Best Medical Treatment Is Best For Most Asymptomatic Cases: A Best Medical Treatment Enthusiast Interprets CREST And Other Data
  Presenter(s):Peter R.F. Bell, MD, FRCS, DSC, KBE  
2:53 PM - 2:58 PM The ICSS Trial: Why Were The Results Of ICSS So Different From CREST, Or Were They: Why Is ICSS Ignored In The U.S.
  Presenter(s):Jonathan D. Beard, MD  
2:59 PM - 3:04 PM It Is Not Possible To Justify CAS For Patients With Atherosclerotic Carotid Disease
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
3:05 PM - 3:11 PM Panel Discussion
Moderator(s): Peter R.F. Bell, MD, FRCS, DSC, KBE / Giorgio M. Biasi, MD  
3:11 PM - 3:16 PM DEBATE: Current Medical Intervention Alone Is Superior To CEA And CAS For Asymptomatic Carotid Arterial Disease
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
3:17 PM - 3:22 PM DEBATE: We Can Now Select Asymptomatic Carotid Stenosis Patients Who Require CEA Or CAS With Confidence
  Presenter(s):Andrew N. Nicolaides, MS, FRCS  
3:23 PM - 3:28 PM Do Statins And Medical Therapy Reduce Carotid Plaque Size, Embolic Potential And The Risk Of Stroke
  Presenter(s):Christos D. Liapis, MD  
3:29 PM - 3:34 PM Details Of CREST Data With Regard To Patientsí Symptomatic Status And Quality Of Life: Does A Minor MI Have More Serious Implications For Longevity Than A Minor Stroke Ė As Some Have Claimed
  Presenter(s):Thomas G. Brott, MD  
3:35 PM - 3:40 PM The AHA/ACC/ASA/SVS/Etc. Guidelines Are Misguided: CAS Is Not Yet An ďAlternativeĒ To CEA For Most Symptomatic Patients
  Presenter(s):Frank J. Veith, MD  
3:41 PM - 3:46 PM Carotid Stenosis Is A Rare Cause Of Stroke With Cardiac Surgery: Rarely Is CEA Or CAS Needed Before Or With Cardiac Surgery: When Is That
  Presenter(s):A. Ross Naylor, MD, FRCS  
3:47 PM - 4:00 PM Panel Discussion/Break
Visit Exhibits and Pavilions (2nd and 3rd Floors)

END OF SESSION 20
 
SESSION 21 SCHEDULE
Thursday
SESSION 21: NEW DEVELOPMENTS IN LOWER EXTREMITY STENT-GRAFTS (5-MINUTE TALKS)
x
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR
4:00 PM - 4:05 PM Building A New Higher Neo-Aortic Bifurcation With Balloon Expandable Covered Stents (Atrium) Is A Better Way To Treat Severe Aortoiliac Occlusive Disease
  Presenter(s):Peter C.J. Goverde, MD  
4:06 PM - 4:11 PM Can 5 mm Diameter Stent-Grafts Be Used For SFA Occlusive Disease: Is Oversizing Stent-Grafts Good Or Bad: What Are The Modes Of Failure
  Presenter(s):Richard R. Saxon, MD, FSIR  
4:12 PM - 4:17 PM Are Stent-Grafts Better Than Bare Metal Stents In The SFA: The VIASTAR Results
  Presenter(s):Johannes Lammer, MD  
4:18 PM - 4:23 PM Are Long Stent-Grafts In The SFA Better Than Multiple Overlapping Shorter Devices: Current Status Of Heparin Bonded Stent-Grafts: Restenosis Does Not Correlate With Lesion Length
  Presenter(s):Thomas Zeller, MD  
4:24 PM - 4:29 PM What Is The Best Current Treatment For In Stent Restenosis
  Presenter(s):Marc Bosiers, MD  
4:30 PM - 4:35 PM Open Femoropopliteal PTFE Bypasses Are Superior To Endoluminal Stent-Graft Bypasses For 5-25 cm SFA Occlusions
  Presenter(s):Mauri J.A. Lepantalo, MD  
4:36 PM - 4:41 PM Lessons Learned In The Treatment Of Popliteal Aneurysms With Stent-Grafts: What Percentage Of Patients Can Be Treated: When Is Stent-Graft Treatment Contraindicated: What Are Recent Graft Improvements
  Presenter(s):Eric L.G. Verhoeven, MD, PhD  
4:42 PM - 4:47 PM Long-Term Comparison Of Endo And Open Popliteal Aneurysm Repair: What Is The Current Role For Open Repair
  Presenter(s):Martin R. Back, MD / Dennis F. Bandyk, MD  
4:48 PM - 4:53 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Thursday
SESSION 22: NEW OR UPDATED CONCEPTS IN VASCULAR DISEASE OR ITS TREATMENT: CONTROVERSY OVER THE INTERVENTIONAL TREATMENT OF CCSVI IN MULTIPLE SCLEROSIS (5-MINUTE TALKS)
x
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR
4:53 PM - 4:58 PM How To Identify Vulnerable Plaques And What To Do About Them
  Presenter(s):Gregg W. Stone, MD  
4:59 PM - 5:04 PM Modern Methods For Accurately Predicting Cardiac Risk In Vascular Surgery Patients
  Presenter(s):Jack L. Cronenwett, MD  
THE CCSVI CONTROVERSY IN MULTIPLE SCLEROSIS
5:05 PM - 5:10 PM Basics For Endovascular Treatment Of Multiple Sclerosis (MS): How Can Duplex Identify Large Vein Stenosis: An Enthusiastís View
  Presenter(s):Paolo Zamboni, MD  
5:11 PM - 5:16 PM Does Interventional Treatment Help MS Patients: A Skepticís View
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
5:17 PM - 5:22 PM Interventional Treatment Of CCSVI For MS: An Interventionalistís Doubts And Hopes
  Presenter(s):Claudio Rabbia, MD, PhD  
5:23 PM - 5:28 PM Is Endovascular Treatment Going To Work For MS Patients: Status Of The PREMISE Randomized Controlled Trial: A Neuro-Interventionalistís View
  Presenter(s):L. Nelson Hopkins, MD  
5:29 PM - 5:34 PM Extracranial Venous Obstruction In MS: Where Is It, What Can Be Done About It, How Do We Know It Works: Importance Of Pressure Gradients And Collaterals: An Interventionalistís View
  Presenter(s):Michael D. Dake, MD  
5:35 PM - 5:40 PM Treatment Of Venous Obstruction Helps MS Patients: A Vascular Surgeonís View
  Presenter(s):Manish Mehta, MD, MPH  
5:41 PM - 5:46 PM Interventional Treatment Of CCSVI For MS: Are Its Benefits Due To A Placebo Effect Or Are They Real: A Skeptical Neuro-Interventionalist's View (Web-Based)
  Presenter(s):Kieran Murphy, MD  
5:47 PM - 5:52 PM Submassive Pulmonary Emboli, An Unrecognized And Often Fatal Condition: Incidence, Diagnosis And Treatment With Ultrasonic Thrombolysis
  Presenter(s):Tod C. Engelhardt, MD  
5:53 PM - 5:58 PM Angiovac Endovascular Clot Removal System For Treatment Of Massive Pulmonary Emboli And Removal Of Large Clot Burdens
  Presenter(s):Christopher J. Kwolek, MD  
5:59 PM - 6:09 PM Panel Discussion
END OF SESSION 22
 
SESSION 23 SCHEDULE
Thursday
SESSION 23: PREVENTION AND TREATMENT OF COMPLICATIONS (5-MINUTE TALKS)
x
PLENARY SESSIONS (SESSIONS 19 - 23) - LOCATION: GRAND BALLROOM, 3RD FLOOR
6:09 PM - 6:14 PM Crossover Balloon Occlusion To Facilitate Percutaneous EVAR, TEVAR, TAVI And To Control Iliac Artery Ruptures And Femoral Artery Injuries
  Presenter(s):Mathew R. Williams, MD / Martin B. Leon, MD  
6:15 PM - 6:20 PM How Can Rhythm Disturbances Detected By An Implantable EKG Monitor (The REVEAL System) Help In Vascular Patient Management
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
6:21 PM - 6:26 PM Tips And Tricks To Protect Interventionalists, Surgeons And Others From Radiation Exposure
  Presenter(s):Lindsay Machan, MD  
6:27 PM - 6:32 PM Antiplatelet Treatment Resistance In Vascular Disease Treatment: How Common Is It: How To Detect It: What Should Be Done About It
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
6:33 PM - 6:38 PM DEBATE: Should We Test For Clopidogrel Resistance In Vascular Patients: No, Itís Not Worth The Time Or Money
  Presenter(s):Erich Minar, MD  
6:39 PM - 6:44 PM DEBATE: Yes! Look At The Coronary Data
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
6:45 PM - 6:50 PM Panel Discussion
6:50 PM - 6:50 PM THURSDAY PROGRAM ENDS
END OF SESSION 23